Roche launches Pegasys for hepatitis C treatment
Roche Scientific Company (I) has launched Pegasys for treating hepatitis C in India following the approval by the drug controller general of India (DCGI). Pegasys is the only pegylated interferon
Roche Scientific Company (I) has launched Pegasys for treating hepatitis C in India following the approval by the drug controller general of India (DCGI). Pegasys is the only pegylated interferon